- Home
- FATE vs EPSN Comparison
FATE vs EPSN Comparison
Compare FATE & EPSN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FATE
- EPSN
- Stock Information
- Founded
- FATE 2007
- EPSN 2005
- Country
- FATE United States
- EPSN Canada
- Employees
- FATE N/A
- EPSN N/A
- Industry
- FATE Biotechnology: Biological Products (No Diagnostic Substances)
- EPSN Oil & Gas Production
- Sector
- FATE Health Care
- EPSN Energy
- Exchange
- FATE Nasdaq
- EPSN Nasdaq
- Market Cap
- FATE 116.5M
- EPSN 100.2M
- IPO Year
- FATE 2013
- EPSN N/A
- Fundamental
- Price
- FATE $1.06
- EPSN $4.84
- Analyst Decision
- FATE Buy
- EPSN
- Analyst Count
- FATE 7
- EPSN 0
- Target Price
- FATE $3.92
- EPSN N/A
- AVG Volume (30 Days)
- FATE 2.1M
- EPSN 166.3K
- Earning Date
- FATE 11-12-2025
- EPSN 11-05-2025
- Dividend Yield
- FATE N/A
- EPSN 5.16%
- EPS Growth
- FATE N/A
- EPSN 11.33
- EPS
- FATE N/A
- EPSN 0.27
- Revenue
- FATE $8,470,000.00
- EPSN $45,709,605.00
- Revenue This Year
- FATE N/A
- EPSN $41.35
- Revenue Next Year
- FATE N/A
- EPSN N/A
- P/E Ratio
- FATE N/A
- EPSN $18.77
- Revenue Growth
- FATE N/A
- EPSN 46.76
- 52 Week Low
- FATE $0.66
- EPSN $4.36
- 52 Week High
- FATE $3.50
- EPSN $8.50
- Technical
- Relative Strength Index (RSI)
- FATE 37.34
- EPSN 48.90
- Support Level
- FATE $1.00
- EPSN $4.36
- Resistance Level
- FATE $1.51
- EPSN $5.06
- Average True Range (ATR)
- FATE 0.15
- EPSN 0.19
- MACD
- FATE -0.05
- EPSN 0.03
- Stochastic Oscillator
- FATE 6.38
- EPSN 68.57
About FATE Fate Therapeutics Inc.
Fate Therapeutics Inc is a clinical-stage biopharmaceutical company based in the United States. It is engaged in the development of programmed cellular immunotherapies for cancer and autoimmune disorders. The company's cell therapy pipeline is comprised of NK- and T-cell immuno-oncology programs, including off-the-shelf engineered product candidates derived from clonal master iPSC lines, and immuno-regulatory programs, including product candidates to prevent life-threatening complications in patients.
About EPSN Epsilon Energy Ltd. Common Share
Epsilon Energy Ltd is engaged in the acquisition, development, gathering, and production of natural gas and oil reserves. The operating segments of the company include Upstream segment activities including acquisition, development, and production of natural gas reserves on properties within the United States. The Gas Gathering segment partners with two other companies to operate a natural gas gathering system, and the corporate segment activities include corporate listing and governance functions of the corporation. The company generates revenue from the sale of crude oil and natural gas.